Top Science Startups in 2024

TrialSpark is transforming the way new medical treatments are brought to market. We’re a technology company that runs end-to-end clinical trials through a network of our own TrialSpark-operated trial sites, making the entire lifecycle of clinical trials more efficient, accessible, and patient-centric. We're growing quickly and would love to have you join us!

Life is short—do something that matters! We are Academia.edu. Our mission is to accelerate and democratize the world's research, which increases the velocity of scientific discovery and technological progress, which benefits everyone. Who we are We are building the world’s largest network for sharing and finding academic research online. With over 260M registered users and nearly half of the world’s academics using our platform monthly, Academia.edu has a significant global reach. By joining our team, you will have the chance to make a positive and lasting impact on our users around the globe. Our users include researchers, academics, industry professionals, and college students. Our company has over 340,000 paying premium subscribers, which has resulted in positive cash flow. This puts us in a unique position to disrupt the $25 billion academic publishing industry. Our ~100-person team, which includes ~45 Software Engineers, values curiosity, initiative, teamwork, and collaboration. We are passionate about building a great work environment that produces excellent products. Academia has attracted $62 million in investment from leading VC firms, including Khosla Ventures, True Ventures, Spark Capital, and Tencent. Our work has garnered favorable attention from trade and mainstream media, including UK Times, Fortune, Wired, EdTech, Venture Beat, San Francisco Business Times, The Economist, The Washington Post, TechCrunch, Scientific American, and Forbes.

BenchSci's vision is to bring medicine to patients 50% faster by 2025. The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work®, and top-ranked company on Glassdoor.

Ripple Effect provides professional consulting and exceptional talent for federal, private, and non-profit clients to deliver some of the most crucial policies and programs that shape our nation. We are researchers and communicators, scientists, analysts and more, driven by curiosity and a commitment to positively impact health, safety and prosperity.

Consensus is an AI-powered search engine designed to make searching for and consuming scientific research paper easier. Our product was launched in the winter of 2022 and we currently serve millions of students, researchers, doctors and consumers alike from across the world.

We believe that the key to solving the grand challenges that humanity is facing is in: 1) science, 2) translating science to innovation on the market, 3) and intense collaboration between all ecosystem stakeholders. We believe this requires bringing transparency to the scientific ecosystem, so no one is limited by whom one happens to know. We believe this requires unlocking access to advanced scientific intelligence for the 99%. We believe that anyone should be able to reach for the stars, with minimal friction in their journey from ideation to innovation. That’s why we took action. In the past eight years, we built a scientific intelligence platform that allows to find a few clicks the most relevant scientific experts, research groups, biotech startups, pharma companies, publications, ongoing projects, patents, clinical trials, press releases... and find answers to specific questions via our LLM integration. Our platform is used by leading pharma, biotech, enablers and academics to make better data-driven decisions, faster. More info here: academiclabs.com/customers Some of our customers call us a "google for science". And, yes, this is our grand ambition. Interested in joining our rollercoaster and having real impact on society? Happy to talk! To learn more about our product: - Website: academiclabs.com - Try our application without signing up: app.academiclabs.com/search Follow us on LinkedIn here: linkedin.com/company/academiclabs

Want to advance the frontiers of understanding? we develop innovative open source software platforms and integrate them into research, processes, and products. cmake, paraview, the visualization toolkit (vtk), and the insight segmentation and registration toolkit (itk) are among the platforms that complement our expertise in computer vision, data and analytics, high-performance computing and visualization, medical computing, and software process management. from meaningful work, to flexible hours, to collaboration, to a hardware budget, to tech lunches, to a clothing stipend, to family outings, there are many reasons to join us and make an impact.

The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges—from eradicating disease and improving education, to addressing the needs of our local communities. Across our focus areas — Science, Education, Community and alongside our Justice & Opportunity partners — we pair technology with grantmaking, impact investing, and collaboration to help accelerate the pace of progress towards an equitable future. We engage directly in the communities we serve because no one understands how to address our society’s challenges better than those who live them everyday. These partners help us identify problems and opportunities, learn fast and iterate toward our audacious goals for the next century. We strive to be humble, empathetic and scrappy life-long learners who work collaboratively to develop community-centered solutions.

Esalen is a leading center for exploring and realizing human potential through experience, education, and research.
 We work toward the realization of a more just, creative, and sustainable world, seeking answers to questions unlikely to be explored by traditional universities and religions.
 We sponsor pioneering initiatives and offer personal, spiritual, and social transformation programs for residents, interns and workshop participants.

There are currently four proprietary platforms, SmartCube®, NeuroCube®, PhenoCube® and eCube™. Using these platforms PsychoGenics can screen tens of thousands of compounds for CNS activity and identify those with a behavioral/physiological profile that reverses a disease model phenotype or that are similar to drugs that treat a specific neuropsychiatric disorder. The company’s technologies are being applied to discover treatments for psychiatric, cognitive, neurodegenerative, and seizure disorders, and pain. We partner and provide services to biotech, pharma, and non-profit organizations interested in developing new treatments.